Item


Multi-residue method for the analysis of pharmaceuticals and some of their metabolites in bivalves

A fast, simple and robust method has been developed for the simultaneous determination of 23 pharmaceuticals (including some major metabolites) in bivalve mollusks. The analytes belong to eight different therapeutic groups: antibiotics, psychiatric drugs, analgesics/anti-inflammatories, tranquilizer, calcium channel blockers, diuretic, and prostatic hyperplasia. The method is based on pressurized liquid extraction (PLE) followed by solid phase extraction clean-up (SPE), and ultra performance liquid chromatography–triple quadrupole mass spectrometry (UHPL–MS/MS) for the identification and quantification of the target analytes. It has been developed and validated in three different species of bivalves: Crassostrea gigas (Pacific oyster), Mytilus galloprovincialis (Mediterranean mussel), and Chamelea gallina (striped venus clam). The majority of the compounds were extracted with a recovery between 40 and 115%. The developed analytical method allowed the determination of the compounds in the lower ng/g concentration levels. The relative standard deviation was under 12% for the intra-day and 20% inter-day analyses, respectively. Finally, the method was applied to oyster, clam and mussel samples collected from the Ebro delta, Spain. The most ubiquitous compounds detected were the psychiatric drug venlanfaxine and the antibiotic azithromycin, with the highest concentrations found in mussel (2.7 ng/g dw) and oyster (3.0 ng/g dw), respectively. To the best of our knowledge, this is the first time that azithromycin has been reported in environmental samples of marine biota

The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007 2013) under the EC safe SEAFOOD project (grant agreement no.311820). The scientific facilities of ICRA have been cofinanced by the Spanish Ministry of Economy and Competitiveness (MINECO) and by the European Regional Development Fund (ERDF) in the frame of the Catalonia ERDF Operative programme 2007–2013. This work was partly supported by the Generalitat de Catalunya (Consolidated Research Group: Catalan Institute for Water Research 2014 SGR 291)

© Talanta, 2015, vol. 136, p. 174-182

Elsevier

Author: Álvarez-Muñoz, Diana
Huerta Buitrago, Belinda
Fernández Tejedor, M.
Rodríguez Mozaz, Sara
Barceló i Cullerés, Damià
Date: 2015
Abstract: A fast, simple and robust method has been developed for the simultaneous determination of 23 pharmaceuticals (including some major metabolites) in bivalve mollusks. The analytes belong to eight different therapeutic groups: antibiotics, psychiatric drugs, analgesics/anti-inflammatories, tranquilizer, calcium channel blockers, diuretic, and prostatic hyperplasia. The method is based on pressurized liquid extraction (PLE) followed by solid phase extraction clean-up (SPE), and ultra performance liquid chromatography–triple quadrupole mass spectrometry (UHPL–MS/MS) for the identification and quantification of the target analytes. It has been developed and validated in three different species of bivalves: Crassostrea gigas (Pacific oyster), Mytilus galloprovincialis (Mediterranean mussel), and Chamelea gallina (striped venus clam). The majority of the compounds were extracted with a recovery between 40 and 115%. The developed analytical method allowed the determination of the compounds in the lower ng/g concentration levels. The relative standard deviation was under 12% for the intra-day and 20% inter-day analyses, respectively. Finally, the method was applied to oyster, clam and mussel samples collected from the Ebro delta, Spain. The most ubiquitous compounds detected were the psychiatric drug venlanfaxine and the antibiotic azithromycin, with the highest concentrations found in mussel (2.7 ng/g dw) and oyster (3.0 ng/g dw), respectively. To the best of our knowledge, this is the first time that azithromycin has been reported in environmental samples of marine biota
The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007 2013) under the EC safe SEAFOOD project (grant agreement no.311820). The scientific facilities of ICRA have been cofinanced by the Spanish Ministry of Economy and Competitiveness (MINECO) and by the European Regional Development Fund (ERDF) in the frame of the Catalonia ERDF Operative programme 2007–2013. This work was partly supported by the Generalitat de Catalunya (Consolidated Research Group: Catalan Institute for Water Research 2014 SGR 291)
Format: application/pdf
ISSN: 0039-9140
Document access: http://hdl.handle.net/10256/12614
Language: eng
Publisher: Elsevier
Collection: Reproducció digital del document publicat a: http://dx.doi.org/10.1016/j.talanta.2014.12.035
Articles publicats (ICRA)
info:eu-repo/grantAgreement/EC/FP7/311820
Is part of: © Talanta, 2015, vol. 136, p. 174-182
Rights: Tots els drets reservats
Subject: Contaminants
Pollutants
Contaminants persistents
Persistent pollutants
Mar -- Contaminació
Marine pollution
Title: Multi-residue method for the analysis of pharmaceuticals and some of their metabolites in bivalves
Type: info:eu-repo/semantics/article
Repository: DUGiDocs

Subjects

Authors